1. Trang chủ
  2. » Khoa Học Tự Nhiên

báo cáo hóa học: " Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients" ppt

1 378 0
Tài liệu đã được kiểm tra trùng lặp

Đang tải... (xem toàn văn)

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 1
Dung lượng 164,51 KB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

CORRECTION Open AccessVascular endothelial growth factor-A VEGF-A and chemokine ligand-2 CCL2 in amyotrophic lateral sclerosis ALS patients Pawan K Gupta1†, Sudesh Prabhakar1†, Suresh Sh

Trang 1

CORRECTION Open Access

Vascular endothelial growth factor-A (VEGF-A)

and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients

Pawan K Gupta1†, Sudesh Prabhakar1†, Suresh Sharma2and Akshay Anand1*

Abstract

Correction to Gupta P K, Prabhakar S, Sharma S, Anand A Vascular endothelial growth factor-A (VEGF-A) and

chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients Journal of Neuroinflammation 8:47.

Correction

The authors observe that, in Table two of our study [1],

crude ORs and adjusted ORs for serum VEGFA were

also repeated for CSF VEGFA, however, these values for

CSF VEGFA are different from serum VEGFA Correct

OR values of CSF VEGFA are given below.

Smoking: [crude OR(95% CI) = 1.7 (0.3-9.1), p = 0.4;

adj OR (95% CI) = 0.6 (0.08-4.4), p = 0.6].

Alcohol consumption: [crude OR(95% CI) = 0.6

(0.1-2.2), p = 0.4; adj OR (95% CI) = 0.8 (0.1-4.4), p = 0.8].

Meat consumption: [crude OR(95% CI) = 2.2 (0.6-7.7),

p = 0.2; adj OR (95% CI) = 2.1 (0.5-7.7), p = 0.2].

Author details

1

Department of Neurology, Post Graduate Institute of Medical Education and

Research (PGIMER), Chandigarh-160012, India.2Department of Statistics,

Panjab University, Chandigarh-160012, India

Received: 8 August 2011 Accepted: 11 August 2011

Published: 11 August 2011

Reference

1 Gupta PK, Prabhakar S, Sharma S, Anand A: Vascular endothelial growth

factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral

sclerosis (ALS) patients.J Neuroinflammation 8:47

doi:10.1186/1742-2094-8-97

Cite this article as: Gupta et al.: Vascular endothelial growth factor-A

(VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral

sclerosis (ALS) patients.Journal of Neuroinflammation 2011 8:97

Submit your next manuscript to BioMed Central and take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit

* Correspondence: akshay1anand@rediffmail.com

† Contributed equally

1

Department of Neurology, Post Graduate Institute of Medical Education and

Research (PGIMER), Chandigarh-160012, India

Full list of author information is available at the end of the article

Guptaet al Journal of Neuroinflammation 2011, 8:97

NEUROINFLAMMATION

© 2011 Gupta et al; licensee BioMed Central Ltd This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Ngày đăng: 19/06/2014, 22:20

TỪ KHÓA LIÊN QUAN

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

🧩 Sản phẩm bạn có thể quan tâm